دورية أكاديمية
Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 Pandemic.
| العنوان: | Factors Influencing Patient Preferences for Telehealth Cancer Genetic Counseling During the COVID-19 Pandemic. |
|---|---|
| المؤلفون: | Breen KE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Tuman M; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY., Bertelsen CE; Department of Strategy and Innovation, Memorial Sloan Kettering Cancer Center, New York, NY., Sheehan M; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Wylie D; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Fleischut MH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Offit K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Stadler ZK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Salo-Mullen EE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY., Hamilton JG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY. |
| المصدر: | JCO oncology practice [JCO Oncol Pract] 2022 Apr; Vol. 18 (4), pp. e462-e471. Date of Electronic Publication: 2021 Oct 15. |
| نوع المنشور: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Alexandria, Va. : American Society of Clinical Oncology, [2020]- |
| مواضيع طبية MeSH: | COVID-19*/epidemiology , Neoplasms*/epidemiology , Neoplasms*/therapy , Telemedicine*, Adult ; Aged ; Female ; Genetic Counseling ; Humans ; Male ; Middle Aged ; Pandemics ; Patient Preference ; SARS-CoV-2 |
| مستخلص: | Purpose: With onset of the COVID-19 pandemic, telehealth became the primary modality for health care appointments. This study examined patient experiences with and preferences for telehealth at a cancer genetic counseling clinic throughout the first 6 months of the pandemic (March-August 2020). Methods: An anonymous survey assessed patient demographics; usage and prior experience with technology; emotional responses, technical experiences, and satisfaction with the telehealth appointment (via the Genetic Counseling Satisfaction Scale and Visit-Specific Satisfaction Questionnaire); preference for future telehealth; and recommendation of telehealth to others. Results: Among 380 respondents, most were highly satisfied with the telehealth appointment (with 65.6% and 66.4% of participants completing the Genetic Counseling Satisfaction Scale and Visit-Specific Satisfaction Questionnaire, respectively). Multivariable analyses indicated several notable findings. Adjusting for relevant covariates, participants with less education felt significantly more concerned about telehealth than those with highest educational attainment. Participants age 40-69 years were generally more comfortable, relieved, and grateful that their appointment was scheduled as telehealth than were those older than 70 years. Women were marginally more relieved and grateful for telehealth appointments than men. As the pandemic progressed, significantly more participants were highly satisfied with their telehealth appointment and participants trended toward having greater preferences for future telehealth use. Most participants (78.6%) would recommend telehealth to others, although 50.8% preferred future in-person appointments. Conclusion: As the pandemic progressed, patients expressed increasing preferences for and satisfaction with telehealth. Service delivery models that incorporate individual patient preferences should be developed with special consideration to factors such as age, sex, and education level. Competing Interests: Kelsey E. BreenStock and Other Ownership Interests: Imago Pharma (I), Isabl Technologies (I)Consulting or Advisory Role: DarwinHealth (I), Imago Pharma (I), Karyopharm Therapeutics (I), Emendo (I)Patents, Royalties, Other Intellectual Property: Royalty from licensing agreements with MI Bioresearch (I) Corinna E. BertelsenEmployment: BioReference Laboratories Zsofia K. StadlerConsulting or Advisory Role: Allergan (I), Genentech/Roche (I), Regeneron (I), Optos (I), Adverum (I), Novartis (I), Regenxbio (I), Gyroscope (I), Neurogene (I)No other potential conflicts of interest were reported. |
| References: | Med Care. 1988 Apr;26(4):393-402. (PMID: 3352332) Genet Med. 2005 Jan;7(1):21-7. (PMID: 15654224) Twin Res Hum Genet. 2011 Aug;14(4):343-6. (PMID: 21787118) J Telemed Telecare. 2000;6(4):245-7. (PMID: 11027129) Gend Work Organ. 2021 Jan;28(Suppl 1):243-249. (PMID: 32904915) Acad Med. 2021 Jun 1;96(6):813-816. (PMID: 33003040) J Genet Couns. 2010 Oct;19(5):463-72. (PMID: 20411313) Patient Educ Couns. 2017 Jun;100(6):1073-1082. (PMID: 28174067) Am J Med Genet C Semin Med Genet. 2021 Mar;187(1):28-36. (PMID: 33225573) Mol Genet Genomic Med. 2020 Oct;8(10):e1433. (PMID: 32743952) J Genet Couns. 2004 Aug;13(4):293-304. (PMID: 19736695) J Genet Couns. 2019 Jun;28(3):673-691. (PMID: 30825358) J Med Syst. 2017 Feb;41(2):21. (PMID: 27987158) J Telemed Telecare. 2011;17(1):36-40. (PMID: 21097566) Prenat Diagn. 2020 Jul;40(8):1040-1041. (PMID: 32314399) J Biomed Inform. 2009 Apr;42(2):377-81. (PMID: 18929686) J Community Support Oncol. 2016 Apr;14(4):162-8. (PMID: 27152515) Genet Med. 2020 Sep;22(9):1467-1469. (PMID: 32499605) J Telemed Telecare. 2006;12(4):182-5. (PMID: 16774698) J Med Genet. 2022 Jan;59(1):23-27. (PMID: 33067353) J Genet Couns. 2015 Dec;24(6):961-70. (PMID: 25833335) Am J Med Genet A. 2021 Jan;185(1):68-72. (PMID: 33051968) Global Health. 2020 Jul 6;16(1):57. (PMID: 32631403) Telemed J E Health. 2018 Feb;24(2):130-138. (PMID: 28737998) Telemed J E Health. 2021 May;27(5):508-512. (PMID: 32946364) JCO Glob Oncol. 2020 Jul;6:1046-1051. (PMID: 32639877) J Med Internet Res. 2020 Sep 9;22(9):e20786. (PMID: 32810841) Genet Med. 2011 Nov;13(11):933-41. (PMID: 21799430) Science. 2020 May 15;368(6492):724. (PMID: 32409466) Gynecol Oncol. 2016 Oct;143(1):109-112. (PMID: 27416795) Int J Nurs Stud Adv. 2020 Nov;2:100008. (PMID: 33083791) Rev Econ Househ. 2020;18(4):1001-1017. (PMID: 32922242) J Telemed Telecare. 2001;7 Suppl 2:68-70. (PMID: 11747665) |
| معلومات مُعتمدة: | P30 CA008748 United States CA NCI NIH HHS; T32 CA009461 United States CA NCI NIH HHS |
| تواريخ الأحداث: | Date Created: 20211015 Date Completed: 20220414 Latest Revision: 20230701 |
| رمز التحديث: | 20240628 |
| مُعرف محوري في PubMed: | PMC9014422 |
| DOI: | 10.1200/OP.21.00301 |
| PMID: | 34652959 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2688-1535 |
|---|---|
| DOI: | 10.1200/OP.21.00301 |